Holford NHG and Sheiner LB "Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models", Clin Pharmacokin 6:429-453 (1981)-The Backstory
- PMID: 22005903
- PMCID: PMC3231857
- DOI: 10.1208/s12248-011-9306-5
Holford NHG and Sheiner LB "Understanding the Dose-Effect Relationship-Clinical Application of Pharmacokinetic-Pharmacodynamic Models", Clin Pharmacokin 6:429-453 (1981)-The Backstory
Figures

Similar articles
-
Pharmacokinetic-pharmacodynamic relationship.Ann Rech Vet. 1990;21 Suppl 1:29S-40S. Ann Rech Vet. 1990. PMID: 2080844 Review.
-
Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.Int J Clin Pharmacol Ther. 1998 Mar;36(3):168-75. Int J Clin Pharmacol Ther. 1998. PMID: 9562234
-
Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meeting.Expert Opin Drug Metab Toxicol. 2010 Dec;6(12):1599-604. doi: 10.1517/17425255.2010.529899. Epub 2010 Oct 24. Expert Opin Drug Metab Toxicol. 2010. PMID: 20969486
-
Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.Anesthesiology. 2003 Aug;99(2):324-33. doi: 10.1097/00000542-200308000-00014. Anesthesiology. 2003. PMID: 12883405
-
Pharmacokinetic and pharmacodynamic variability: a daunting challenge in drug therapy.Curr Drug Metab. 2007 Feb;8(2):109-36. doi: 10.2174/138920007779816002. Curr Drug Metab. 2007. PMID: 17305491 Review.
Cited by
-
Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers.Pharm Res. 1991 Feb;8(2):263-8. doi: 10.1023/a:1015864709082. Pharm Res. 1991. PMID: 2023879
-
Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers.Eur J Clin Pharmacol. 1994;46(1):29-33. doi: 10.1007/BF00195912. Eur J Clin Pharmacol. 1994. PMID: 8005183 Clinical Trial.
-
Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study.Ann Med. 2023;55(2):2264850. doi: 10.1080/07853890.2023.2264850. Epub 2023 Dec 10. Ann Med. 2023. PMID: 38071661 Free PMC article. Clinical Trial.
-
Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.Cardiovasc Drugs Ther. 1989 Jun;3(3):417-25. doi: 10.1007/BF01858113. Cardiovasc Drugs Ther. 1989. PMID: 2487538
References
-
- Rosenbaum JS, Holford NH, Richards ML, Aman RA, Sadee W. Discrimination of three types of opioid binding sites in rat brain in vivo. Mol Pharmacol. 1984;25(2):242–248. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources